SNIP1 anticorps (Middle Region)

N° du produit ABIN927453

Détail du produit anti-SNIP1 anticorps

Antigène: SNIP1 (Smad Nuclear Interacting Protein 1 (SNIP1))

Épitope: Middle Region

Reactivité: Humain, Rat, Souris, Boeuf (Vache), Chien

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp SNIP1 est non-conjugé

Application: Western Blotting (WB)

Réactivité croisée: Souris, Rat (Rattus), Boeuf (Vache), Chien

Purification: Purified

Immunogène: SNIP1 antibody was raised in rabbit using the middle region of SNIP1 as the immunogen

Information d'application

Indications d'application: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

SNIP1 Blocking Peptide, catalog no. 33R-8075, is also available for use as a blocking control in assays to test for specificity of this SNIP1 antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Détails sur SNIP1

Antigène: SNIP1 (Smad Nuclear Interacting Protein 1 (SNIP1))

Autre désignation: SNIP1 (SNIP1 Produits)

Synonymes: anticorps MGC75890, anticorps snip1a, anticorps SNIP1, anticorps PMRED, anticorps 2410133M08Rik, anticorps Smad nuclear interacting protein 1, anticorps Smad nuclear interacting protein 1 S homeolog, anticorps smad nuclear interacting protein 1, anticorps MYST/Esa1 associated factor 6, anticorps snip1, anticorps snip1.S, anticorps SNIP1, anticorps CC1G_02914, anticorps PTRG_06240, anticorps MEAF6, anticorps Snip1

Sujet: Smad-binding peptide aptamers can be developed to selectively inhibit TGF-beta-induced gene expression. Synonyms: Polyclonal SNIP1 antibody, Anti-SNIP1 antibody, Smad nuclear interacting protein 1 antibody.

Pathways: SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2